Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Danish Medical Journal|December 21, 2013
Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancerTrine Zeeberg Iversen
Basic & Clinical Pharmacology & Toxicology|September 11, 2014
The targeting of indoleamine 2,3 dioxygenase -mediated immune escape in cancerTrine Zeeberg Iversen, Mads Hald Andersen, Inge Marie Svane
Stem Cell Investigation|October 24, 2017
Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanomaNikolaj Juul Nitschke, Jon Bjoern, Trine Zeeberg Iversen, et al.
Cytotherapy|July 6, 2016
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumabJon Bjoern, Trine Zeeberg Iversen, Nikolaj Juul Nitschke, et al.
Oncoimmunology|May 4, 2016
Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with IpilimumabJon Bjoern, Nikolaj Juul Nitschke, Trine Zeeberg Iversen, et al.
Frontiers in Immunology|October 5, 2018
Durable Clinical Responses and Long-Term Follow-Up of Stage III-IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study-A Brief Research ReportJulie Westerlin Kjeldsen, Trine Zeeberg Iversen, Lotte Engell-Noerregaard, et al.
Ugeskrift for Laeger|January 5, 2018
[Multicentric reticulohistiocytosis is a rare form of paraneoplasia]Anna Maria Anderson, Tanja Todberg, Kristian Kofoed, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2015
Multinational study exploring patients' perceptions of side-effects induced by chemo-radiotherapyChristina H Ruhlmann, Trine Zeeberg Iversen, Meena Okera, et al.
The Journal of Investigative Dermatology|September 28, 2012
Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusionMarco Donia, Morten Hansen, Sarah L Sendrup, et al.
Cancer Immunology, Immunotherapy : CII|March 20, 2012
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trialEva Ellebaek, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, et al.
Pageof 2